Saturday, October 31, 2026

ProLogis And 2 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 2, 2023

ProLogis  And 2 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - ProLogis (PLD), U.S. Physical Therapy (USPH), Sun Communities (SUI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. ProLogis (PLD)

13.5% sales growth and 6.53% return on equity

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At September 30, 2023, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (114 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment.

Earnings Per Share

As for profitability, ProLogis has a trailing twelve months EPS of $3.14.

PE Ratio

ProLogis has a trailing twelve months price to earnings ratio of 37.37. Meaning, the purchaser of the share is investing $37.37 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.53%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter is a negative 9.5% and positive 26% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Sep 14, 2023, the estimated forward annual dividend rate is 3.48 and the estimated forward annual dividend yield is 3.58%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ProLogis's EBITDA is 65.38.

Sales Growth

ProLogis's sales growth is 13.7% for the ongoing quarter and 13.5% for the next.

2. U.S. Physical Therapy (USPH)

9.3% sales growth and 7.38% return on equity

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.

Earnings Per Share

As for profitability, U.S. Physical Therapy has a trailing twelve months EPS of $1.7.

PE Ratio

U.S. Physical Therapy has a trailing twelve months price to earnings ratio of 49.83. Meaning, the purchaser of the share is investing $49.83 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.38%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Nov 14, 2023, the estimated forward annual dividend rate is 1.72 and the estimated forward annual dividend yield is 2.03%.

3. Sun Communities (SUI)

9.1% sales growth and 3.16% return on equity

Established in 1975, Sun Communities, Inc. became a publicly owned corporation in December 1993. The Company is a fully integrated REIT listed on the New York Stock Exchange under the symbol: SUI. As of September 30, 2023, the Company owned, operated, or had an interest in a portfolio of 670 developed MH, RV and Marina properties comprising approximately 180,170 developed sites and approximately 48,030 wet slips and dry storage spaces in the U.S., the UK and Canada.

Earnings Per Share

As for profitability, Sun Communities has a trailing twelve months EPS of $1.81.

PE Ratio

Sun Communities has a trailing twelve months price to earnings ratio of 72.55. Meaning, the purchaser of the share is investing $72.55 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.16%.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com